Growing community of inventors

Denver, CO, United States of America

Leland Shapiro

Average Co-Inventor Count = 1.00

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 104

Leland ShapiroCharles A Dinarello (43 patents)Leland ShapiroEli C Lewis (0 patent)Leland ShapiroEli C Lewis (0 patent)Leland ShapiroLeland Shapiro (10 patents)Charles A DinarelloCharles A Dinarello (43 patents)Eli C LewisEli C Lewis (0 patent)Eli C LewisEli C Lewis (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. University of Colorado (5 from 1,379 patents)

2. Bioholding, Inc. (2 from 2 patents)

3. Other (1 from 832,718 patents)

4. University Technology Corporation (1 from 80 patents)

5. University of Technology (1 from 6 patents)


10 patents:

1. 10913790 - Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules

2. 9695229 - Compositions of, and methods for, alpha-1 antitrypsin Fc fusion molecules

3. 9499606 - Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules

4. 8633305 - Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules

5. 8071551 - Methods and compositions for treating diabetes

6. 7850970 - Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections

7. 7807781 - Inhibitors of serine protease activity and their use in methods and compositions for treatment of viral infections

8. 7704958 - Methods and compositions for inhibiting apoptosis using serine protease inhibitors

9. 6849605 - Inhibitors of serine protease activity, methods and compositions for treatment of viral infections

10. 6489308 - Inhibitors of serine protease activity, methods and compositions for treatment of nitric-oxide-induced clinical conditions

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/12/2025
Loading…